African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Malaria Journal Année : 2019

African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker

Didier Leroy
  • Fonction : Auteur
Fiona Macintyre
  • Fonction : Auteur
Nimol Khim
  • Fonction : Auteur
  • PersonId : 764211
  • IdRef : 184142334

Résumé

Background: Today, the development of new and well-tolerated anti-malarial drugs is strongly justified by the emergence of Plasmodium falciparum resistance. In 2014–2015, a phase 2b clinical study was conducted to evaluate the efficacy of a single oral dose of Artefenomel (OZ439)–piperaquine (PPQ) in Asian and African patients presenting with uncomplicated falciparum malaria. Methods: Blood samples collected before treatment offered the opportunity to investigate the proportion of multidrug resistant parasite genotypes, including P. falciparum kelch13 mutations and copy number variation of both P. falciparum plasmepsin 2 (Pfpm2) and P. falciparum multidrug resistance 1 (Pfmdr1) genes. Results: Validated kelch13 resistance mutations including C580Y, I543T, P553L and V568G were only detected in parasites from Vietnamese patients. In Africa, isolates with multiple copies of the Pfmdr1 gene were shown to be more frequent than previously reported (21.1%, range from 12.4% in Burkina Faso to 27.4% in Uganda). More strikingly, high proportions of isolates with multiple copies of the Pfpm2 gene, associated with piperaquine (PPQ) resistance, were frequently observed in the African sites, especially in Burkina Faso and Uganda (> 30%). Conclusions: These findings were considered to sharply contrast with the recent description of increased sensitivity to PPQ of Ugandan parasite isolates. This emphasizes the necessity to investigate in vitro susceptibility profiles to PPQ of African isolates with multiple copies of the Pfpm2 gene and estimate the risk of development of PPQ resistance in Africa.
Fichier principal
Vignette du fichier
Leroy_et_al_Malar_J_2019.pdf (1.73 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

hal-02558674 , version 1 (30-04-2020)

Identifiants

Citer

Didier Leroy, Fiona Macintyre, Yeka Adoke, Serge Ouoba, Aissata Barry, et al.. African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker. Malaria Journal, 2019, 18, pp.126. ⟨10.1186/s12936-019-2756-4⟩. ⟨hal-02558674⟩
71 Consultations
41 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More